{
    "title": "US grants emergency approval to Lilly Covid-19 antibodies",
    "url": "https://www.dailymail.co.uk/wires/afp/article-8932087/US-grants-emergency-approval-Lilly-Covid-19-antibodies.html",
    "date": "2020-11-10",
    "keywords": [
        "bamlanivimab",
        "drug",
        "covid19",
        "disease",
        "emergency",
        "antibody",
        "treatment",
        "risk",
        "trial",
        "patient",
        "approval",
        "hospitalization",
        "room",
        "coronavirus",
        "fda",
        "percent",
        "placebo",
        "immune",
        "electron",
        "micrograph",
        "virus",
        "niaid",
        "research",
        "facility",
        "food",
        "administration",
        "monday",
        "dose",
        "mildtomoderate",
        "form",
        "action",
        "development",
        "availability",
        "agencys",
        "chief",
        "stephen",
        "midstage",
        "mild",
        "statement",
        "evidence",
        "frequency",
        "side",
        "majority",
        "severity",
        "dizziness",
        "headache",
        "itchiness",
        "dosage",
        "caveat",
        "benefit",
        "stage",
        "bodys",
        "damage",
        "month",
        "safety",
        "incident",
        "class",
        "cancer",
        "host",
        "lab",
        "surface",
        "protein"
    ],
    "category": [
        "wires",
        "afp"
    ]
}